Improving the outcome of liver transplantation with very old donors with updated selection and management criteria

被引:93
作者
Cescon, Matteo [1 ]
Grazi, Gian Luca [1 ]
Cucchetti, Alessandro [1 ]
Ravaioli, Matteo [1 ]
Ercolani, Giorgio [1 ]
Vivarelli, Marco [1 ]
D'Errico, Antonietta [2 ]
Del Gaudio, Massimo [1 ]
Pinna, Antonio Danielle [1 ]
机构
[1] Univ Bologna, Dept Surg & Transplantat, Liver & Multiorgan Transplant Unit, I-40138 Bologna, Italy
[2] Univ Bologna, Felice Addarii Inst, Dept Hematol & Oncol, Div Pathol, I-40138 Bologna, Italy
关键词
D O I
10.1002/lt.21433
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Advanced donor age is a risk factor for poor outcome in liver transplantation (LT). We reviewed 553 consecutive transplants according to donor age categories [group 1 (n = 173): < 50 years; group 2 (n = 96): 50-59 years; group 3 (n = 132): 60-69 years; group 4 (n = 111): 70-79 years; group 5 (n 41): >= 80 years]. Clinical parameters were comparable between groups. Group 5 had the highest proportion of pretransplant liver biopsy (85%), with only 1 graft showing macrovesicular steatosis > 30%, and the lowest ischemia time. Five-year graft survival was significantly higher in group 1 (75%) versus groups 3 (60%) and 4 (62%; P = 0.01 and P = 0.001, respectively) and in group 5 (81 %) versus groups 3 and 4 (P = 0.04 and P = 0.01, respectively). Donor age of 60-79 years, recipient hepatitis C virus-positive status, Model for End-Stage Liver Disease score >= 25, and emergency LT were predictors of poor survival. In hepatitis C virus-positive patients, 5-year graft survival was 72% in group 1, 85% in group 2, 52% in group 3, 65% in group 4, and 71% in group 5 (group 1 versus group 3, P = 0.04; group 2 versus group 3, P = 0.03). In conclusion, older donor grafts managed with routine graft biopsy and short ischemia time may work effectively, regardless of the severity of the recipient's liver disease.
引用
收藏
页码:672 / 679
页数:8
相关论文
共 24 条
[1]   3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome [J].
Burroughs, AK ;
Sabin, CA ;
Rolles, K ;
Delvart, V ;
Karam, V ;
Buckels, J ;
O'Grady, JG ;
Castaing, D ;
Klempnauer, J ;
Jamieson, N ;
Neuhaus, P ;
Lerut, J ;
de Goyet, JD ;
Pollard, S ;
Salizzoni, M ;
Rogiers, X ;
Muhlbacher, F ;
Valdecasas, JCG ;
Broelsch, C ;
Jaeck, D ;
Berenguer, J ;
Gonzalez, EM ;
Adam, R .
LANCET, 2006, 367 (9506) :225-232
[2]   The utility of marginal donors in liver transplantation [J].
Busuttil, RW ;
Tanaka, K .
LIVER TRANSPLANTATION, 2003, 9 (07) :651-663
[3]   Split liver transplantation [J].
Busuttil, RW ;
Goss, JA .
ANNALS OF SURGERY, 1999, 229 (03) :313-321
[4]   Effect of nonviral factors on hepatitis C recurrence after liver transplantation [J].
Cameron, Andrew M. ;
Ghobrial, Rafik M. ;
Hiatt, Jonathan R. ;
Carmody, Ian C. ;
Gordon, Sherilyn A. ;
Farmer, Douglas G. ;
Yersiz, Hasan ;
Zimmerman, Michael A. ;
Durazo, Francisco ;
Han, Steve H. ;
Saab, Sammy ;
Gornbein, Jeffrey ;
Busuttil, Ronald W. .
ANNALS OF SURGERY, 2006, 244 (04) :563-571
[5]   Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation:: A randomized controlled study [J].
Carrion, Jose A. ;
Navasa, Miquel ;
Garcia-Retortillo, Montserrat ;
Garcia-Pagan, Juan Carlos ;
Crespo, Gonzalo ;
Bruguera, Miquel ;
Bosch, Jaime ;
Forns, Xavier .
GASTROENTEROLOGY, 2007, 132 (05) :1746-1756
[6]   Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation [J].
Castells, L ;
Vargas, V ;
Allende, H ;
Bilbao, I ;
Lázaro, JL ;
Margarit, C ;
Esteban, R ;
Guardia, J .
JOURNAL OF HEPATOLOGY, 2005, 43 (01) :53-59
[7]  
Demetris AJ, 1997, HEPATOLOGY, V25, P658
[8]   Characteristics associated with liver graft failure: The concept of a donor risk index [J].
Feng, S ;
Goodrich, NP ;
Bragg-Gresham, JL ;
Dykstra, DM ;
Punch, JD ;
DebRoy, MA ;
Greenstein, SM ;
Merion, RM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (04) :783-790
[9]  
GRAZI GL, 1994, TRANSPLANT P, V26, P3651
[10]  
Lake JR, 2005, AM J TRANSPLANT, V5, P549, DOI 10.1111/j.1600-6143.2005.00741.x